Larvol Delta - Residual-Disease-Driven-Strategy-for-CARCIK-CD19-in-AdultsPediatric-BCPALL

CARCIK-CD19 - CoImmune

http://clinicaltrials.gov/ct2/show/NCT05252403

Feb 23, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next